Dayong Si

Mechanism of CYP2C9 Inhibition by Flavones and Flavonols

Dayong Si, Ying Wang, Yihan Zhou et al. · Drug Metabolism and Disposition · 2008 · 163 citations

Medicine, Medicinal Chemistry, Pharmacology +16

Identification of a novel variant CYP2C9 allele in Chinese

Dayong Si, Yingjie Guo, Yifan Zhang et al. · Pharmacogenetics · 2004 · 91 citations

Medicine, Genetics, Pharmacology +16

ROLE OF CYP2C9 AND ITS VARIANTS (CYP2C9*3 AND CYP2C9*13) IN THE METABOLISM OF LORNOXICAM IN HUMANS

Yingjie Guo, Yifan Zhang, Ying Wang et al. · Drug Metabolism and Disposition · 2005 · 64 citations

Medicine, Genetics, Pharmacology +13

Influence of CYP2C9 and CYP2C19 genetic polymorphisms on pharmacokinetics of gliclazide MR in Chinese subjects

Yifan Zhang, Dayong Si, Xiaoyan Chen et al. · British Journal of Clinical Pharmacology · 2007 · 63 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +13

Lornoxicam pharmacokinetics in relation to cytochrome P450 2C9 genotype

Yifan Zhang, Dafang Zhong, Dayong Si et al. · British Journal of Clinical Pharmacology · 2004 · 51 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +16